Ngā hua rapu - Stephen C. Mathai
- E whakaatu ana i te 1 - 20 hua o te 60
- Haere ki te Whārangi Whai Ake
-
1
Pulmonary Arterial Hypertension in Connective Tissue Diseases mā Stephen C. Mathai, Paul M. Hassoun
I whakaputaina 2012Revisão -
2
Management of interstitial lung disease associated with connective tissue disease mā Stephen C. Mathai, Sonye K. Danoff
I whakaputaina 2016Revisão -
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Serum uric acid as a marker of disease risk, severity, and survival in systemic sclerosis‐related pulmonary arterial hypertension mā Catherine E. Simpson, Rachel L. Damico, Laura K. Hummers, Rubina Khair, Todd M. Kolb, Paul M. Hassoun, Stephen C. Mathai
I whakaputaina 2019Artigo -
12
-
13
Risk assessment in scleroderma patients with newly diagnosed pulmonary arterial hypertension: application of the ESC/ERS risk prediction model mā Valentina Mercurio, Nermin Diab, Grace Peloquin, Traci Housten-Harris, Rachel L. Damico, Todd M. Kolb, Stephen C. Mathai, Paul M. Hassoun
I whakaputaina 2018Carta -
14
Investigating the “sex paradox” in pulmonary arterial hypertension: Results from the Pulmonary Hypertension Association Registry (PHAR) mā Jacqueline T. DesJardin, Noah Kime, Nicholas A. Kolaitis, Richard A. Kronmal, Matthew R. Lammi, Stephen C. Mathai, Corey E. Ventetuolo, Teresa De Marco
I whakaputaina 2024Artigo -
15
-
16
Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction mā Khalil Bourji, Benjamin W. Kelemen, Stephen C. Mathai, Rachel L. Damico, Todd M. Kolb, Valentina Mercurio, Franco Cozzi, Ryan J. Tedford, Paul M. Hassoun
I whakaputaina 2017Artigo -
17
Long‐Term Outcomes in Patients With Connective Tissue Disease–Associated Pulmonary Arterial Hypertension in the Modern Treatment Era: Meta‐Analyses of Randomized, Controlled Trials... mā Dinesh Khanna, Carol Zhao, Rajan Saggar, Stephen C. Mathai, Leland W.K. Chung, Gerry Coghlan, Mehul Shah, John M. Hartney, Vallerie V. McLaughlin
I whakaputaina 2021Revisão -
18
Clinical trial design and new therapies for pulmonary arterial hypertension mā Olivier Sitbon, Mardi Gomberg‐Maitland, John Granton, Michael I. Lewis, Stephen C. Mathai, Maurizio Rainisio, Norman Stockbridge, Martin R. Wilkins, Roham T. Zamanian, Lewis J. Rubin
I whakaputaina 2018Revisão -
19
Prognostic value of the pre-transplant diastolic pulmonary artery pressure–to–pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertensi... mā Ryan J. Tedford, Claude A. Beaty, Stephen C. Mathai, Todd M. Kolb, Rachel L. Damico, Paul M. Hassoun, Peter J. Leary, David A. Kass, Ashish S. Shah
I whakaputaina 2013Artigo -
20
Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension mā Arantza Campo, Stephen C. Mathai, Jérôme Le Pavec, Ari Zaiman, Laura K. Hummers, Danielle Boyce, Traci Housten, Noah Lechtzin, Hala El Chami, Reda E. Girgis, Paul M. Hassoun
I whakaputaina 2011Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Internal medicine
Pulmonary hypertension
Cardiology
Heart failure
Pathology
Hemodynamics
Confidence interval
Intensive care medicine
Vascular resistance
Cohort
Disease
Hazard ratio
Nursing
Blood pressure
Physical therapy
Quality of life (healthcare)
Ejection fraction
Inoculation
Lung
Proportional hazards model
Scleroderma (fungus)
Clinical trial
Systemic scleroderma
Cardiac output
Contractility
Environmental health
Gastroenterology
Interstitial lung disease
Population